🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this research study is to explore ways to improve motor, cog...
Status
Completed
Location
Washington University School of Medicine
Start Date
2025-07-28
Trial ID
NCT07000734
Treatments Being Tested
This placebo-controlled study is designed to determine the efficacy, safety...
Status
Unknown
Location
The Medical Research Network, LLC
Start Date
2014-12
Trial ID
NCT02294305
Treatments Being Tested
Depression in patients with type 2 diabetes is often undiagnosed and remain...
Status
Completed
Location
Multiple Locations
Start Date
2016-06-30
Trial ID
NCT03978286
Treatments Being Tested
The purpose of this Venlafaxine-referenced study is to evaluate the efficac...
Status
Completed
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT00839423
Treatments Being Tested
The purpose of the study is to evaluate long-term safety and tolerability o...
Status
Completed
Location
Multiple Locations
Start Date
2008-05
Trial ID
NCT00694304
Treatments Being Tested
The purpose of this study is to determine the safety and efficacy of vortio...
Status
Completed
Location
Multiple Locations
Start Date
2008-06
Trial ID
NCT00734071
Treatments Being Tested
The purpose of this study is to find out if vortioxetine is better than pla...
Status
Terminated
Location
Alliance for Research
Start Date
2021-08-10
Trial ID
NCT05014919
Treatments Being Tested
The purpose of this study is to evaluate the bioequivalence of a single ora...
Status
Completed
Location
Nishi Kumamoto Hospital
Start Date
2018-02-16
Trial ID
NCT03437564
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, safety and tolerabil...
Status
Completed
Location
Multiple Locations
Start Date
2010-08
Trial ID
NCT01179516
Treatments Being Tested
To assess the efficacy of vortioxetine (10 to 20 mg/day) as adjunctive trea...
Status
Completed
Location
EE001
Start Date
2014-10
Trial ID
NCT02279953
Treatments Being Tested